Genetics of bipolar disorder by Escamilla, Michael A. & Zavala, Juan M.
ipolar affective disorder, type I (BP-I) is a
severe mental illness marked by periodic extremes of
mood state (manias),as well as (in most cases) episodes
of depression and (in many cases) psychosis.The conse-
quences of BP-I are severe,and involve both direct and
indirect issues. Rates of suicide in BP-I patients are
high,
1,2 and BP-I subjects also suffer from poorer quality
of life and lower productivity than unaffected individu-
als.
3 Annual public health costs (combined direct and
indirect) of BP have been estimated to be between 24 bil-
lion and 45 billion dollars.
4,5 BP-I occurs in all populations
that have been studied, with lifetime prevalence rates
worldwide of the order of one per every 100 individuals.
6
Segregation analyses,adoption studies,and twin studies
have consistently shown that,regardless of the popula-
tion studied, genetic factors play an important role in
determining one's risk of developing BP-I.
7-9 Since little
is known about the actual etiology of BP,it would be a
major contribution to our understanding of the patho-
physiology of BP if the genes responsible for the neuro-
biologic changes which underlie this disorder could be
identified.The difficulty in finding genetic loci that are
involved in BP most likely derives from the complex
nature of the illness.When multiple transmission models
for BP-I (the most severe form of BP) have been tested,
oligogenic epistatic models are found to be the best fit,
rather than models which purport one major locus.
Craddock et al
10 reviewed epidemiologic,family,and twin
studies,and showed that two,three,or four locus models
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Bipolar disorder, especially the most severe type (type I),
has a strong genetic component. Family studies suggest
that a small number of genes of modest effect are
involved in this disorder. Family-based studies have iden-
tified a number of chromosomal regions linked to bipolar
disorder, and progress is currently being made in identi-
fying positional candidate genes within those regions. A
number of candidate genes have also shown evidence of
association with bipolar disorder, and genome-wide asso-
ciation studies are now under way, using dense genetic
maps. Replication studies in larger or combined datasets
are needed to definitively assign a role for specific genes
in this disorder. This review covers our current knowledge
of the genetics of bipolar disorder, and provides a com-
mentary on current approaches used to identify the genes
involved in this complex behavioral disorder.  
© 2008, LLS SAS Dialogues Clin Neurosci. 2008;10:141-152.of BP-I were formally consistent with observed data,but
suggested that a three- or four-locus model (with site-spe-
cific λR of 1.7 to 2.0) best fit the parameters of their
mathematical models of BP-I transmission.Indeed,the
concordance for BP in monozygotic twins (0.67),when
compared with concordance in dizygotic twins (0.10 to
0.20)
11 and the relative risk in first-degree relatives (0.10
to 0.20),
12 strongly suggests that more than one locus is
involved.
13 Moreover,genome scans from several groups
have been conducted to date on the “BP spectrum”phe-
notype,with evidence for a “BP”gene locus varying by
study,including findings of possible loci on chromosome
18q21-23,
14-17 chromosome 4p12-13,
18,19 chromosome
13q31-33,
20 and other loci (see section on linkage scans
below).Tellingly,no study has shown predominant link-
age to just one site in their sample,even when the sam-
ple is drawn from a more homogenous population.
19,27
Although reasonably strong evidence for linkage has
been found in several studies (an LOD score of 3.8 in 20
pedigrees,
21 a multipoint LOD score of 3.92 in 2 families
from Quebec,
22 a combined linkage/association score of
4.01 in two Costa Rican pedigrees
15), replication and
identification of genes for BP has been elusive.
Overcoming the key obstacles to mapping BP gene loci
(etiological heterogeneity,imprecision in the definition of
affected phenotypes,and uncertainty regarding mode of
genetic transmission),will likely require the collection of
a very large sample of families, consisting of rigorously
diagnosed BP-I individuals drawn from genetically homo-
geneous populations. The National Institute of Mental
Health Genetics Initiative
23 was driven by the philosophy
that disorders such as BP may have quite low genetic risk
ratios for any given locus.While this is based in part on the
failure of previous studies to identify and replicate a BP
locus,we do not feel that this failure in previous studies
should be taken as proof that no major locus for a BP gene
exists.Rather,it is clear that no previous study in the field
of bipolar genetics has focused on the most severe phe-
notype (BP-I) in a large-scale study which utilizes sib-pair
and nonparametric analyses to attempt to map predispo-
sition genes.If current estimates that there are a few (or at
least one to two) loci with genetic (locus-specific) risk
ratios for BP-I above 1.5 are correct,
10 failure to identify
these loci may be attributed to problems in phenotype def-
inition (only recently have studies restricted analyses to
BP-I,
27,28,29-41 heterogeneity of the samples (few have
focused on a single ethnic group),model specification dif-
ficulties,and insufficient sample sizes.
Recent advances in identifying genes for schizophrenia
(SC) are of particular interest here.In early linkage stud-
ies of SC,researchers initially relied heavily on SC spec-
trum diagnoses which included schizotypal disorder,brief
psychosis,and others,before limiting their “affected cat-
egory” to the most reliably diagnosed, narrowest, and
most severe phenotype,SC itself.Following years of stud-
ies reporting weak and nonreplicable findings,substan-
tial evidence for SC gene loci finally came from studies
that confined themselves to a narrow diagnostic classi-
fication (SC only), focused on many small families
(mostly sib pairs),and concentrated on one major ethnic
group.
42,43 In these studies, sib-pair or nonparametric
analyses were used to identify loci on chromosomes 13
and 8. In each case, subsequent studies supported SC
genes being linked to these loci.This has led to identifi-
cation of genes in both regions,
44,45 which give strong evi-
dence of being SC predisposition genes and,in turn,stim-
ulated a reappraisal of the pathogenic mechanisms
underlying SC.
46
Bipolar genetic research is currently at a similar state to
where research on SC was prior to the studies by Blouin
et al
43 and Pulver et al.
42 BP mapping studies conducted
up until 2004 (and most since that time) consisted of
small sample sizes (from 1 to 98 pedigrees) with wide
phenotype definitions (BP-I,BP-II and recurrent depres-
sion).In the last couple of years,a few larger sets of data,
such as the that from the Wellcome Trust UK and
Ireland
47 have been analyzed.At best, with very small
sample sizes,previous studies have narrowed the pheno-
typic definition to “BP-I and BP-II”—yet, even these
subtypes of BP have questionable congruence at the bio-
logic level (many studies,for instance,now suggest that
BP-I and BP-II are fundamentally different illnesses).
48-50
While it is true that the BP spectrum includes BP-I,BP-
II,and recurrent depression at some level,
9 past genetic
mapping studies have shown clearly that using this broad
definition of BP cannot successfully identify the genes
involved in any of these categorical illnesses.Such stud-
ies actually might work against being able to find BP
genes, as the population prevalence of the combined
“extended”phenotype increases (the lifetime prevalence
of depression in women from the United States, for
instance, is over 10% in both the Epidemiological
Catchment Area [ECA] and National Comorbidity
Survey [NCS] studies) while the heritability of their pro-
posed phenotype decreases (depression is less heritable
than mania).
12
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51-53 and
most genetic form of BP,
12 yet almost all previous genetic
studies of BP have failed to study the BP-I phenotype
without clouding the picture by including BP-II and
recurrent depression in the phenotype definition. No
doubt, a major limitation to performing studies on the
most severe phenotype,BP-I,has been the fact that find-
ing families with large sibships,who are intact and agree-
able to participate, has been prohibitively difficult in
mainstream United States society.Indeed,the original
NIMH Bipolar Genetics Initiative, consisting of three
sites (Washington University in St Louis, Indiana
University, and Johns Hopkins University) collected a
total of only 145 affected sib pairs with the most severe
diagnosis (BP-I or schizoaffective,bipolar) over 10 years,
as their pedigree selection was based,whether by design
or practicality,on a wider phenotype (NIMH Center for
Genetic Studies;http://zork.wustl.edu/nimh).
Risch and Merikangas
54 have estimated that for a genetic
risk ratio of λ=1.5, approximately 500 sib pairs will be
necessary to have adequate power of mapping a disease
gene in an outbred population such as that of the United
States,although they acknowledge that in a more homo-
geneous population the number of sib pairs needed may
be less.The difficulty of obtaining such samples may be
the most important limiting factor in confirming linkage
analysis of BP,as evidenced by recent efforts to develop
multicenter collaborations for pedigree collections for
both SC
55 and BP.
12 Nevertheless,there have been a num-
ber of linkages reported to BP spectrum diseases, as
described in the next section.
Linkage studies
Pedigree-based linkage analyses have been quite suc-
cessful in identifying the genes for hundreds of simple
Mendelian diseases (like Huntington’s disease),and for
a few complex diseases (like early-onset Alzheimer’s and
early-onset breast cancer).Although a few groups have
focused on a small number of large, extended pedi-
grees,
27,56 due to the difficulty of obtaining large multiplex
families,genome-wide scans using dense maps of poly-
morphic markers in small pedigrees have become the
standard strategy for finding bipolar genes through link-
age.
57To circumvent problems inherent in complex dis-
eases, nonparametric methods have recently been uti-
lized, where mode of inheritance, allele frequency, or
penetrance parameters (currently unknown for bipolar
disorder) are not needed to assess linkage between phe-
notype and genotype.In what may be a preview of things
to come, investigators from several countries recently
pooled their genotypic information from 11 different
genome-wide linkage scans,(with a total sample of 5179
individuals from 1067 families), and found successful,
genome-wide significant evidence of linkage to chromo-
somes 6q and 8q.
Table I summarizes key findings from a number of link-
age analyses performed over the last 20 years,indicating
the chromosomal regions, phenotypes focused on, and
the LOD scores for each region.As we increase our sam-
ple sizes (mainly through collaborative efforts from mul-
tiple sites),improve the phenotypic definition of bipolar
disorder (possibly through endophenotype discoveries)
and discover improved meta-analysis tools, it is hoped
that linkage analyses will assist the field in better under-
standing where the most critical loci for bipolar disorder
(predisposition genes of moderate effect) are located in
the human genome. In the current excitement over
genome-wide association (GWA) analyses (see section
below),it would certainly be unwise to overlook the ben-
efits of family-based linkage analyses to contribute to the
identification of genes for complex diseases.
Association studies
Candidate genes
Until recently,it was not practical to consider GWA stud-
ies to try to detect genes for bipolar disorder.To screen
the whole genome and detect genes that are associated
with bipolar disorder requires that the gene variant
responsible for the phenotype (ie,bipolar disorder) is in
tight linkage disequilibrium with the variant (typically
either a microsatellite or a single nucleotide polymor-
phism,SNP) being studied.Linkage disequilibrium is a
technical term that indicates that two genetic loci are so
close that specific alleles for the loci segregate together
more often than would be expected by chance.At the
genome level,areas of linkage disequilibrium,at least in
outbred populations,are very small,
79 thus requiring that
hundreds of thousands of SNPs be genotyped per person.
Although such studies are now becoming possible (see
the “Genome-wide Association Studies”section below),
many investigators have focused on particular genes,to
determine whether they might be associated with bipo-
lar disorder. This candidate gene approach usually
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Table I. Bipolar linkage studies. *, multilocus ASP analysis; **, Genome scan meta-analysis (GSMA); *** multipoint nonparametric (NPl) and para-
metric linkage analyses; æ, Multiple scan probability (MSP); BP-I, bipolar disorder type I; BP-II, bipolar disorder type II); SABP, schizoaffective
disorder, bipolar type; UPR, recurrent unipolar depression; MD, major depression; SCA, schizoaffective disorder; SC, schizophrenia; MDD-R,
major depressive disorder recurrent
Chromosomal region        Phenotype Main author Reference Maximum LOD 
(marker) Score
1p35-p36 (DSM-IV) BP-I, BP-II, SABP, or recurrent MD Schumacher J et al 59 (NPL=3.97)***
1q31-q32 BP-I, BP-II with major depression, SCA, and UPR Detera-Wadleigh SD et al 20 2.67
1q42 (D1S2800) (DSM-IV) SABP, BP-I, or SC Hamshere ML et al 58 3.54
2p13-16 BP-I or SCA-manic type Liu J et al 44 3.20
2q24 SCA-manic type, BP-I, BP-II with recurrent MD Zandi PP et al 60 1.99
3q14 (D3S1300) BP-I or BP-II or SABP, regardless of age of onset,  Etain B et al 61 (NPL=3.51)***
or if they had a major depressive episode 
with an age of onset of ≤21
3p21 (D3S1285) BP-I McInnes LA et al 27 2.26
3q28 (D3S2418) SCA-manic type, BP-I, BP-II with recurrent MD, or MDD-R Zandi PP et al 60 1.94
4p (D4S394) BP-I and BP-II Blackwood DH et al 18 4.1
4q12-q21 (D4S392) BP-I, BP-II with MD, SCA, and UPR including  Detera-Wadleigh SD et al 20 1.77
individuals with 2 or more episodes of MD
4q21 BP-I, BP-II, SCA and recurrent MD Cassidy F et al 37 (NPL-2.23)***
4q31 (D4S1625) BP-I or SCA-manic type Liu J et al 29 3.16
4q31 (DSM-IV) BP-I, BP-II, SABP, or recurrent MD Schumacher J et al 59 (NPL=5.49)***
4q35 (between D4S3051-4qTEL13) BP-I, BP-II, SCA-manic type, or UPR Badenhop RF et al 62 3.2
Chrom 5 (D5S207) BP-I or SABP, BP-II with recurrent depression, plus UPR Dick DM et al 63 2.8
5q31-33 (D5S2049) BP-I Herzberg I et al 30 (NPL=4.395)***
5q33-34 (GABRA1) BP-I or SCA with presence of hallucinations and delusions Kerner B et al 31 (P<0.00001)
Chrom 6 (108.5 Mb) (DSM-IV, RDC, DSM-III-R) BP-I only McQueen MB et al 32 4.19
6p (D6S7) BP-I (RDC) Ginns EI et al 33 2.2
6q (D6S1021)  BP-I, SABP, BP-II, or UPR Dick DM et al 36 3.61
6q16-q21 (D6S1021) (DSM-IV) BP-I, BP-II, BP-NOS, MDD-R Lambert D et al 47 2.62
6q22 (DSM-IV) BP-I or SABP Pato CN et al 34 3.56 
(NPL=4.20)***
6q24 (DSM-IV) BP-I, BP-II, SABP, or recurrent MD Schumacher J et al 59 (NPL=4.87)***
7p (between D7S1802- D7S1869) BP-I, BP-II, Detera-Wadleigh SD et al 64 (P≤ 0.05)*
and SCA or UPR (RDC and DSM III-R)
7q31 (between D7S1799-D7S501) BP-I, BP-II with MD, and SCA or individuals  Detera-Wadleigh SD et al 20 2.08
with two or more episodes of MD
7q34 (D7S1824) BP-I or SCA-manic type or BP-II Liu J et al 29 2.78
7q36 BP-I, BP-II, SCA, recurrent MD Cassidy F et al 37 (NPL=2.11)***
Chrom 8 (135.4 Mb) DSM-IV, RDC, DSM-III-R) BP-I only McQueen MB et al 32 1.99
8q (D8S256) BP-I or SABP Dick DM et al 36 2.46
8q24 (D8S284) Female participants with history of puerperal psychosis,    Jones I et al 65 2.03
defined as a mania or psychosis with onset within 6 weeks 
of delivery
8q24 (D8S256) Included BP-I, BP-II with UPR, and SABP McInnis M et al 66 2.1
8q24.21-qter BP-I or SABP Segurado R et al 35 (PAvgRnk ≤0.05)**
Chrom 9 (24.5 Mb) (DSM-IV, RDC, DSM-III-R) BP-I only McQueen MB et al 32 2.04
9p21-q21 BP-I, BP-II, SCA and recurrent MD Cassidy F et al 37 (NPL=2.41)***Genetics of bipolar disorder - Escamilla and Zavala Dialogues in Clinical Neuroscience - Vol 10 . No.2 . 2008
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Table I. Continued (and on next page)
Chromosomal region  Phenotype Main author Reference Maximum LOD 
(marker) Score
9p21.1-q21.1 BP-I or SABP Segurado R et al 35 (PAvgRnk ≤0.05)**
Chrom 10 ( D10S1423) SABP, BP-I, and BP-II Foroud T et al 68 2.5
10p (between INS (RDC) BP-I, BP-II, SCA (manic-depressive type),  Egeland et al 56 4.904
and HRAS1) atypical psychosis with prominent affective features,  (note: further analysis of 
and Unipolar MD this data set yielded negative
LOD scores in this region)
10p12 (D10S1423) BP-I, SABP, and BP-II McInnis M et al 67 2.2
10q11.21-q22.1 BP-I or BP-I and SABP Segurado R et al 35 (PAvgRnk=.008)**
10q24 (D10S169) manic syndrome, mostly BP-I Liu J et al 29 2.79
10q25-q26 (D10S217) BP-I, BP-II with major depression, and SCA and those Cichon et al 70 2.86
individuals with two or more episodes of MD
10q26 (D10S217) included bipolar disorder, single episode mania  Ewald et al 69 2.17
or SCA, manic and depressed type
11p15.5 (between  (DSM-III-R and RDC) SABP,  Zandi PP et al 41 (NPL = 2.19 near
D11S1984-D11S2362) BP-I, and BP-II  marker D11S1923, 
peak HLOD of 2.00) ***
12q23-q24 BP-I, SABP, BP-II, and UPR Morissette J et al 72 1.327
12q24 (D12S378) BP-I, SABP and BP-II recurrent episode, and recurrent MD Shink E et al 71 3.35
12q24 BP-I only Cassidy F et al 37 (NPL=2.20)***
13q “SCA, BP-I and BP-II, and narrower models” Badner JA et al 74 (MSP=6x10-6)
ψ
13q14–32 SABP or BP-I Stine OC et al 38 1.12
13q31 (D13S317)  All subjects with a mood disorder Potash JB et al 75 2.52 
(NPL=3.56)***
13q31-q34 BP-I, BP-II, SABP and recurrent MD Kelsoe JR et al 73 2.4
13q32 (between  BP-I, BP-II with MD, SCA and  Detera-Wadleigh SD et al 20 3.5
D13S1252–D13S1271) individuals with two or more episodes of MD
13q32 (near D13S779) manic syndrome, mostly BP-I, plus BP-II Liu J et al 29 2.2
14q24 (D15S1014) BP-I only Cassidy F et al 37 (NPL=3.27)***
15q26 (D15S1014) (DSM-IV) SC, SCA, Bipolar Disorder Vazza G et al 39 (NPL=3.05)***
Chrom 16 (D16S749) BP-I or SABP, BP-II with recurrent depression, and UPR Dick DM et al 63 2.8
16p13 BP-I only Cassidy F et al 37 (NPL=2.23)***
16p13 (D16S423) Female participants with history of puerperal psychosis (see above) Jones I et al 65 4.07
17q (D17S928) BP-I, SABP, BP-II and UPR Dick DM et al 36 3.63
17q11-12 (D17S921) manic syndrome, mostly BP-I Liu J et al 29 2.68
Chrom 18 (D18S21) SCA, BP-I, and BP-II with major depression and UPR Berrettini WH et al 26 2.38
18pter-p11 and  BP-I, SABP BP-II, and recurrent major depressive disorder Segurado R et al 35 (PAvgRnk ≤0.05)**
18p11-q12.3
18p11.2 (between  BP-I, BP-II with MD, and SCA Detera-Wadleigh SD et al 20 2.32
D18S1150–D18S71)
18q22-23 (D18S61) BP-I McInnes et al. 27 2.26
19q13 (D19S221) (DSM-IV) SABP, BP-I, or SC Hamshere ML et al 58 1.85
Chrom 20 (4.2 Mb) (DSM-IV, RDC, DSM-III-R) BP-I only McQueen MB et al 32 1.91
20p12 (D20S162) BP-I, BP-II, SABP, and UPR Willour VL et al 77 1.82 
(nonparametric LOD score of 2.38)
21q22 (PFKL locus) (RDC) Bipolar disorder or recurrent MD Straub RE et al 24 3.41requires an a priori hypothesis that a gene,due to its loca-
tion near a linkage peak and/or because of the function
of its gene product,might play a role in bipolar disorder.
Systematic analyses of genes in peak regions found from
linkage studies have been rare (ie,where all genes under
the linkage peak are carefully screened).However,analy-
ses of genes in these peak regions (positional candidates)
have led to positive associations for a number of genes
on chromosomes including 5,12,13,
80 18,
81-85 and 22.
86A
large number of genes have been studied because of a
hypothesized role based on neurophysiology,including
genes that play a role in circadian rhythms,
87,88 the
dopaminergic pathway (DRD1, DRD4, DAT1
89-91), the
serotinergic pathway (HTTLPR,
92 HTR2A
93), neural
development and neurotrophism (BDNF,
94 NCAM 1
95).
In addition, as genes have been discovered for schizo-
phrenia,investigators have also analyzed whether these
genes might be associated with bipolar disorder,with sev-
eral studies now suggesting that variations in the
Neuregulin 1 gene
96,97 and the G72/30 gene
98,99 are asso-
ciated with bipolar disorder or manic psychosis.
Replication of genetic association studies has been diffi-
cult,in part because the sample sizes necessary to detect
genes are of small effect size.Other difficulties in candi-
date gene studies are similar to problems faced in all
association studies:poorly matched cases and controls
can lead to false-positive or -negative results,definitions
of bipolar disorder vary across studies, and genes may
have different effects based on background population
issues (genetic background and environmental back-
ground).Of all the specific candidate genes shown in one
study or another to be associated with bipolar disorder,
at this point none of these findings have been robust
enough or tested in large enough samples to definitively
implicate them in the genesis of bipolar disorder.
Genome-wide association studies
Recently,with the advent of genetic chips that can ana-
lyze over 500 000 SNPs, and the knowledge-base pro-
vided by analysis of the human genome,it has become
possible to construct GWA studies in outbred popula-
tions.In this approach,a case-control or trio approach
(affected subjects,plus their parents) is utilized,typically
requiring thousands of subjects, and 500 000 or more
SNPs are analyzed in order to determine specific genes
or regions associated with a disorder.The approach has
recently provided promising results in studies of type II
diabetes,cancer,and other medical conditions which can
be classified as common and complex diseases,and this
has led to efforts in the United States, the United
Kingdom,and elsewhere,to pursue GWA studies on a
large scale.
100,101The potential advantage of whole-genome
association studies is that such studies may be able to
pick out associations of genes that do not have major
effect on a disease,and (if the sample size is big enough)
potentially overcome complications when disorders are
multigenic.On the other hand,sample sizes needed for
analyses may be difficult to reach without major invest-
ments,the cost of the technology is not trivial,rare alle-
les with major effects may be overlooked,stratification
issues and multiple testing issues become even more crit-
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Table I. Continued
Chromosomal region  Phenotype Main author Reference Maximum LOD 
(marker) Score
21q (D21S212) BP-Iand BP-II, with major depression and schizoaffectives Detera-Wadleigh SD et al 78 1.79
21q22 (D21S1260) BP-I, unipolar manic, SCA, BP-II, plus UPR and recurrent unipolar Liu J et al 76 3.56
and “individuals who do not quite meet criteria but are 
judged to possibly have above diagnoses”
22q “SCA, bipolar I and bipolar II, and narrower models” Badner JA et al 74 (MSP=3x10-5)
ψ
22q11 (D22S420) (DSM-IV) SABP, BP-I or SC Hamshere ML et al 58 1.96
22q12 (D22S278) (DSM-III-R) BP-I, BP-II, SABP, and recurrent MD Kelsoe JR et al 73 3.84
22q12-13 (D22S277) All subjects with a mood disorder Potash JB et al 75 3.06
Xp22 and Xq26–28 SABP, BP-I anf SABP, BP-I, BP-II (respectively) Stine O et al 38 0.94 and 1.34 
(respectively)
Xp11.3 (GATA144D04) (DSM-III-R) SABP and BP-I Zandi PP et al 41 (NPL =2.19; 
HLOD=2.25) ***
Xq24-q26 (DXS994) BP-I, BP-II, BP-NOS or SCA Pekkarinen P et al 40 3.54ical than in linkage studies,selection of individual cases
may dilute the study of “genetic”forms of bipolar disor-
der,and replication will remain a difficult issue,leading
some to temper the expectations we might expect from
GWA analyses.
102
GWA studies in bipolar disorder were initially pursued
in the Costa Rican population, with microsatellites
placed relatively sparsely across the genome.
103-105
Although these studies yielded potentially interesting
linkage disequilibrium between bipolar disorder and spe-
cific chromosomal regions,the sparseness of the map did
not allow specific genes to be implicated at the screening
level.Two recent GWA studies of bipolar disorder,using
dense SNP maps,have been reported thus far.Baum et
al
106 used a two-stage strategy,beginning with 461 bipolar
cases and 563 controls and following up significant find-
ings in a sample of 772 bipolar cases and 876 controls,
and found evidence for novel genes potentially associ-
ated with bipolar disorder,including a gene for diacyl-
glycerol kinase,which plays a key role in the lithium sen-
sitive phosphatidyl inositol pathway. A study by the
Wellcome Trust Case Control Consortium utilized 2000
bipolar cases and 3000 controls,and reported on a num-
ber of SNPs showing evidence of association, some at
specific loci that had not formerly been implicated in
studies of bipolar disorder. For both of these recent
GWA studies, additional genes or regions have been
added to the list of possible genes involved in bipolar dis-
order.Comparisons across studies,replication studies for
specific genes in new samples, combined analyses and
even larger case-control studies will be necessary to ade-
quately separate the wheat from the chaff.An additional
GWA study of bipolar disorder is currently under way in
the United States,as part of a private-public joint ven-
ture known as the GAIN collaborative group.
100The true
cost versus benefit of such massive ventures,compared
with the potentially more modest costs of continuing and
combining linkage studies and following these up with
focused fine mapping,has yet to be determined.
Endophenotypes
It is known that neuropsychiatric disorders and their
phenotypes do not follow classic Mendelian genetics,
but rather a complex genetic pattern where multiple
genes are involved and environment also modifies the
course of illness.It is the interaction of all these aspects
that lead to the phenotypic appearance of these com-
plex disorders.These difficulties,as well as the relatively
slow process in identifying genes for complex disorders,
has led many investigators to begin to focus on identi-
fying genes for “endophenotypes.”The term endophe-
notype has been defined as an internal, intermediate
phenotype that may fill the gap in the causal chain
between genes and distal diseases.
107An endophenotype
can be an inherited neurophysiological, neuropsycho-
logical, cognitive, neuroanatomical, biochemical, or
endocrinological trait.
108
The current diagnostic and classification of psychiatric dis-
orders is not based on pathophysiology or etiology,but is
based on nosological tradition,expert consensus,psycho-
metric reliability and clinical utility.
109 Endophenotypes,if
accurately defined,could represent more basic biological
phenomena than the more complex related phenotype.
Theoretically,it might then be easier to identify genetic
variants associated with an endophenotype than it would
be to identify variants associated with a more complex
phenotype. Ideally endophenotypes would stem from a
monogenic etiology, but this is generally not the rule.
Because they are often quantitative and occur in affecteds
and unaffecteds,endophenotypes also allow more persons
per family to participate and contribute linkage informa-
tion. Quantitative linkage and association methods can
also be utilized.
In order for an endophenotype to be useful in the iden-
tification of genetic markers for a disorder it must meet
several criteria:(i) it has to be associated with the illness
in the population;(ii) it has to be heritable;(iii) it should
be primarily state-independent (manifests in an individ-
ual whether or not the illness is active);(iv) it should seg-
regate with illness within families; and finally (v) the
endophenotype found in affected family members should
be found in nonaffected family members at a higher rate
than in the general population.
110,111Another aspect which
should be taken into consideration when identifying an
endophenotype is the feasibility and reliability of its mea-
surement.
Following are a number of preliminary studies which sug-
gest possible endophenotypes for bipolar disorder that
derive from neuroanatomy and neuropsychology.
Importantly,we do not know at this point whether any of
these meet all of the criteria necessary to be fully con-
sidered as an endophenotype for bipolar disorder.Future
studies need to be done,especially in terms of measuring
heritability and segregation with disease,for these and
other potential endophenotypes.
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When looking at biological structures of the brain,there
are studies that suggest specific regions of the brain as
endophenotypes for bipolar disorder.MacDonald et al
112
indicated that a genetic risk for bipolar disorder was
specifically associated with gray-matter deficits in the
right anterior cingulate gyrus and ventral striatum.Two
studies revealed that the risk of white-matter abnormal-
ities is more than threefold higher in patients with bipo-
lar disorder than in healthy controls.
113,114A meta-analy-
sis of magnetic resonance imaging (MRI) brain
measurements done in multiple studies reviewed by
McDonald et al
115 showed right lateral ventricular volume
was increased in bipolar subjects.
Potential neuropsychological endophenotypes
Some studies focus on brain function as endophenotypes
for bipolar disorder.Attention deficits have been con-
sidered as an endophenotype,where it was found to be
present early in the disorder and was more pronounced
with recurring episodes of bipolar.
116 Poor performance
on verbal memory tests was consistently found as a char-
acteristic of bipolar disorder.
117 Impaired planning (speed
of information processing) after reduced tryptophan
availability could represent another endophenotype.
118
Lithium is a treatment for bipolar disorder,and has been
shown to modify the phase and period of circadian
rhythms in a variety of species involving the glycogen
synthase kinase 3 (GSK-3) inhibitor.
119,120 There is pre-
liminary evidence of an association between a polymor-
phism in the GSK-3-β promoter gene and bipolar disor-
der, suggesting that genetic factors involved in the
regulation of the human circadian clock might represent
another endophenotype for bipolar disorder.
121
For more thorough reviews of the role of endopheno-
types for bipolar disorder,see refs 122 and 123.
Summary and future directions in genetic
studies of bipolar disorder
The last two decades have been a time of vigorous activ-
ity in the field of bipolar disorder genetic studies.
Although success in the ultimate goals of clearly identi-
fying which genes play a role in this disorder has been
modest,this is not unusual,given the complexity of the
disorder and the challenge of identifying genes for any
disorder that is not caused by a single major gene.
Moving from the pioneering work in the 20th century to
define the genetic basis of bipolar disorder,through care-
fully designed family and twin studies,a number of teams
throughout the world have focused their energies on
gathering large numbers of multiplex families,in order to
carry out genome-wide linkage studies to identify bipo-
lar gene loci.These studies have used fairly modest num-
bers of families,compared with the recommended num-
ber for complex diseases,
54 and, perhaps as could be
expected, the linkage scores have been modest in all
studies published,ranging at best up to LOD scores in
the range of 3 to 4.Although meta-analyses have been
performed,few studies have combined large numbers of
families to interrogate specific loci,with the largest sys-
tematically gathered samples coming primarily from the
NIMH Genetics Consortium and the UK Wellcome Trust
Consortium.Joint analyses combining data from multi-
ple groups are only just now beginning to occur.
32 Smaller
sets of families,from special populations known as “pop-
ulation isolates”
124 have also yielded a number of linkage
regions with modest LOD scores.Systematic fine map-
ping of these regions may yield specific genes of interest
for bipolar disorder,as was seen in similar linkage stud-
ies of schizophrenia.Candidate genes studies have also
yielded a number of potentially associated genes deserv-
ing of further study in combined, large samples. New
technologies now make GWA studies possible,and such
studies will soon add a number of additional genes to the
pool of potentially associated genes for bipolar disorder.
Endophenotype studies will most likely also add a num-
ber of novel genes to consider in terms of how they might
indirectly contribute to bipolar disorder of mood desta-
bilization. Technologies that allow detection of copy
number variants and chromosomal variations,as well as
analyses of methylation patterns (epigenetics),genomic
expression,and proteomic analyses will add further gene
candidates which can be targeted for study at the
genomic level.As each new piece of data comes in from
these studies, a major challenge for the field will be to
sort out and keep track of the various findings.The use
of bioinformatics to review convergent evidence from
multiple types of studies will become a critical compo-
nent of research planning and interpretation of
results.
125,126 Iterative research,in which variants are dis-
covered for a bipolar phenotype,and then those subjects
who carry the variant are studied in more detail (“deep
phenotyping”) may help to more clearly link gene vari-
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148ants to bipolar phenotypes.Ultimately large collabora-
tive studies,which clearly delineate specific phenotypes
(categorical and quantitative) and take population genet-
ics carefully into account,will be needed to,one by one,
determine the exact correlation between gene variants
and risk for the disease (or trait) of interest.
Scientists and clinicians who may have hoped that one or
a few genes would eventually be identified that would
explain the majority of risk for bipolar disorder must face
the reality that there are likely to be many genes of rela-
tively small effect involved in bipolar disorder,and the
genetic dissection of this disorder will be a subtle and
complex process.Genetic testing for bipolar disorder will
likely ultimately require careful weighing of the presence
or absence of many gene variants, when counseling is
being done at the population level.As specific genes are
clearly identified to play a role in bipolar disorder, it
remains quite possible that within specific families or
clusters,genes of moderate effect will be discovered,but
we must face the fact that thus far,no clear bipolar dis-
ease causing variant has been discovered in any family
studied.In the next decade,a feasible goal might be to
clearly implicate at least a handful of genes (through
well-powered replication studies or meta-analyses),from
which the biochemical pathways underlying the disease
can be more thoroughly studied at the level of cell biol-
ogy and physiology. Such approaches may yield clear
pharmacologic targets which can intervene in disease
processes that have their origin in genetic risk variants,
at times by acting on an enzyme or protein that is part of
the biochemical pathway rather than on the gene or gene
product itself.
127
It is likely that over the next decade,the field of bipolar
genetics will shift from the current emphasis on identify-
ing the genes which play a role in this disease,to under-
standing the pathophysiology of the disease from a new
perspective (ie,by study of the pathways tied to the genes
which play a role in the disease).Along with this work,we
might also cautiously expect that bipolar disorder may at
last begin to be understood to be a complex behavioral
phenotype, with many components and subtypes. For a
“disorder”that involves some of the fundamental behav-
iors and experiences of relevance to the human race,
including regulation of activity levels, the ability to feel
euphoria and dysphoria,to control social impulses,to cre-
ate,to have racing thoughts,and to over- or undervalue
one’s capacities,it is perhaps not surprising that the mole-
cular underpinnings of the bipolar condition will prove to
be complex and subtle,and span a multiplicity of gene and
protein networks. Indeed, the gene variants which con-
tribute to bipolar disorder may have evolved because of
their specific value in helping individuals or groups adapt
to socially and physically challenging and changing envi-
ronments.
128To understand the genetics of bipolar disor-
der may,in the end,not be any less of a task than to under-
stand the genetics of human psychology and behavior. ❏
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Genética del trastorno bipolar
El trastorno bipolar, especialmente el tipo más
grave (tipo I), tiene un fuerte componente gené-
tico. Los estudios en familias sugieren que un
pequeño número de genes de efecto modesto
están involucrados en este trastorno. Estudios basa-
dos en familias han identificado un número de
regiones cromosómicas que se relacionan con el
trastorno bipolar y actualmente el progreso está
orientado a identificar la posición de genes candi-
dato dentro de esas regiones. Un número de genes
candidato también ha demostrado evidencia de
asociación con el trastorno bipolar, y actualmente
se están desarrollando estudios de asociación del
genoma completo utilizando numerosos mapas
genéticos. Se requieren estudios de replicación en
conjuntos de datos más grandes o combinados para
asignar definitivamente un papel a genes específi-
cos en este trastorno. Esta revisión cubre nuestro
conocimiento actual de la genética del trastorno
bipolar y entrega un comentario acerca de las apro-
ximaciones actualmente utilizadas para identificar
los genes involucrados en este complejo trastorno
conductual. 
Génétique des troubles bipolaires
Les troubles bipolaires, surtout la forme la plus
sévère (type 1), ont une composante génétique
importante. D’après des études familiales, un petit
nombre de gènes à effet modeste sont impliqués
dans la maladie. Ces mêmes études ont identifié des
régions chromosomiques liées à la maladie bipo-
laire et des progrès sont actuellement réalisés dans
la définition de la position des gènes candidats au
sein de ces régions. L’association d’un certain
nombre de gènes candidats avec la maladie bipo-
laire a été démontrée et des études d’association
avec l’ensemble du génome sont en cours, en uti-
lisant des cartes génétiques denses. Des études de
réplication sur des bases de données plus impor-
tantes ou combinées sont nécessaires pour attribuer
définitivement un rôle à des gènes spécifiques dans
cette maladie. Cet article passe en revue nos
connaissances actuelles sur la génétique des
troubles bipolaires et commente les approches
actuelles d’identification des gènes impliqués dans
ce trouble complexe du comportement.
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